Wind数据显示,截至1月31日,共有283只医药股披露了2025年业绩预告。按预告归母净利润上限看,共有160只个股归母净利润同比增长,其中赛诺医疗成为A股药企“预增王”,最高预增逾32倍。药明康德预计实现净利规模最大,为191.51亿元,这也将创下药明康德上市以来的归母净利润新高。在过半数企业业绩预增的同时,有超120家企业2025年业绩预减,其中有39家面临上市后的首次亏损,包括智飞生物、...
Source LinkWind数据显示,截至1月31日,共有283只医药股披露了2025年业绩预告。按预告归母净利润上限看,共有160只个股归母净利润同比增长,其中赛诺医疗成为A股药企“预增王”,最高预增逾32倍。药明康德预计实现净利规模最大,为191.51亿元,这也将创下药明康德上市以来的归母净利润新高。在过半数企业业绩预增的同时,有超120家企业2025年业绩预减,其中有39家面临上市后的首次亏损,包括智飞生物、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.